A sharp rise in the incidence of XXXX in young adults in Israel.

@entity5 @entity1 @entity978 @entity1733
BACKGROUND: @entity978 is a distinct primary @entity5 of the immune system that shows wide variation in incidence among different geographic regions and among various races. It was previously suggested that susceptible @entity1 living in certain parts of Israel had a higher risk of @entity1733 because of exposure to unidentified environmental factors in these regions. Compared with other parts of Israel, these regions were characterized by a higher proportion of Israeli-born Jews. OBJECTIVES: To study time trends in the incidence rate of @entity1733 in Israeli-born Jews of all age groups during the years 1960-2005. RESULTS: A total of 4812 Jewish cases of @entity1733 were reported to the Israel Cancer Registry during the study period 1960-2005. There has been a persistent increase in the age-standardized incidence rate of @entity1733 , all subtypes pooled, in Israeli-born Jews in both @entity1 and @entity1 . The age distribution pattern in both genders was bimodal in all periods. The highest incidence was observed in the 20-24 year age group: for @entity1 (9.13 per 100,000 per year) during the period 1988-1996, and for @entity1 (6.60 per 100,000 per year) during the period 1997-2005. CONCLUSIONS: The reported incidence level of @entity1733 in Israeli-born young adult Jews in Israel has increased in recent years to high levels compared with other western countries. Our findings suggest a cohort effect to unidentified factors affecting Israeli-born young adult Jews in Israel.
